IDO1 and neoplasm: Another system of nanoparticles can inhibit the indoleamine 2,3-dioxygenase 1 (IDO1) pathway and induce immunogenic cell death to enhance DC maturation, increase the number of CTLs, and decrease the number of Tregs in tumor tissues [96].